Literature DB >> 16478732

The VP2/VP3 minor capsid protein of simian virus 40 promotes the in vitro assembly of the major capsid protein VP1 into particles.

Masa-aki Kawano1, Takamasa Inoue, Hiroko Tsukamoto, Tatsuya Takaya, Teruya Enomoto, Ryou-u Takahashi, Naoki Yokoyama, Noriaki Yamamoto, Akira Nakanishi, Takeshi Imai, Tadashi Wada, Kohsuke Kataoka, Hiroshi Handa.   

Abstract

The SV40 capsid is composed primarily of 72 pentamers of the VP1 major capsid protein. Although the capsid also contains the minor capsid protein VP2 and its amino-terminally truncated form VP3, their roles in capsid assembly remain unknown. An in vitro assembly system was used to investigate the role of VP2 in the assembly of recombinant VP1 pentamers. Under physiological salt and pH conditions, VP1 alone remained dissociated, and at pH 5.0, it assembled into tubular structures. A stoichiometric amount of VP2 allowed the assembly of VP1 pentamers into spherical particles in a pH range of 7.0 to 4.0. Electron microscopy observation, sucrose gradient sedimentation analysis, and antibody accessibility tests showed that VP2 is incorporated into VP1 particles. The functional domains of VP2 important for VP1 binding and for enhancing VP1 assembly were further explored with a series of VP2 deletion mutants. VP3 also enhanced VP1 assembly, and a region common to VP2 and VP3 (amino acids 119-272) was required to promote VP1 pentamer assembly. These results are relevant for controlling recombinant capsid formation in vitro, which is potentially useful for the in vitro development of SV40 virus vectors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478732     DOI: 10.1074/jbc.M511261200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Simian virus 40 transformation, malignant mesothelioma and brain tumors.

Authors:  Fang Qi; Michele Carbone; Haining Yang; Giovanni Gaudino
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

2.  JC virus minor capsid proteins Vp2 and Vp3 are essential for virus propagation.

Authors:  M L Gasparovic; G V Gee; W J Atwood
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

Review 3.  Protein cages, rings and tubes: useful components of future nanodevices?

Authors:  Jonathan G Heddle
Journal:  Nanotechnol Sci Appl       Date:  2008-11-17

4.  The viroporin activity of the minor structural proteins VP2 and VP3 is required for SV40 propagation.

Authors:  Kristina M Giorda; Smita Raghava; Macy W Zhang; Daniel N Hebert
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

5.  Pseudovirions as vehicles for the delivery of siRNA.

Authors:  Paul E Lund; Ryan C Hunt; Michael M Gottesman; Chava Kimchi-Sarfaty
Journal:  Pharm Res       Date:  2009-12-09       Impact factor: 4.200

6.  Effect of dsDNA on the Assembly Pathway and Mechanical Strength of SV40 VP1 Virus-like Particles.

Authors:  Mariska G M van Rosmalen; Chenglei Li; Adam Zlotnick; Gijs J L Wuite; Wouter H Roos
Journal:  Biophys J       Date:  2018-09-13       Impact factor: 4.033

7.  Role of the C-terminal region of vervet monkey polyomavirus 1 VP1 in virion formation.

Authors:  Hiroki Yamaguchi; Shintaro Kobayashi; Junki Maruyama; Michihito Sasaki; Ayato Takada; Takashi Kimura; Hirofumi Sawa; Yasuko Orba
Journal:  J Vet Med Sci       Date:  2014-01-13       Impact factor: 1.267

Review 8.  Components of Adenovirus Genome Packaging.

Authors:  Yadvinder S Ahi; Suresh K Mittal
Journal:  Front Microbiol       Date:  2016-09-23       Impact factor: 5.640

9.  A very late viral protein triggers the lytic release of SV40.

Authors:  Robert Daniels; Dorota Sadowicz; Daniel N Hebert
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

10.  SV40 VP1 major capsid protein in its self-assembled form allows VP1 pentamers to coat various types of artificial beads in vitro regardless of their sizes and shapes.

Authors:  Masaaki Kawano; Koji Doi; Hajime Fukuda; Yoshinori Kita; Kensuke Imai; Takamasa Inoue; Teruya Enomoto; Masanori Matsui; Mamoru Hatakeyama; Yuki Yamaguchi; Hiroshi Handa
Journal:  Biotechnol Rep (Amst)       Date:  2014-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.